TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Sponsor: University of California, San Francisco · Phase: PHASE1/PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 74 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$10,553,600

Rescue Site Savings

+$6,958,780

Unlock Full NCT05359653 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05359653 Rescue Dossier →